🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thrilled to see our article on #hypoxia regulated HILPDA in #NASH #HCC. In press in Journal of Hepatology. Thanks to the amazing co-authors, collaborators and mentors for this amazing work.

Gut->Liver axis is real!! Even my bacteria are excited about the #TLM23 #LiverTwitter ⁦AASLD⁩

Packed room for SharkTank #LiverCancer SIG edition 2. #TLM23 ⁦AASLD⁩

First pitch by Andrew Moon!! Good job Andrew!! #LiverCancerSIG #TLM23 AASLD AASLD Foundation

Proud mentor!!! Outstanding pitch by Peyton Classon from Mayo Clinic Gastroenterology & Hepatology at #LiverCancerSIG Shark tank competition!! AASLD Foundation AASLD #TLM23

Experimental #MASLD AND #MASH session today/Sunday at 4:30 pm, Ballroom A AASLD #TLM23

Learning about CD+ T cells in MASH from Hyun Se Kim Lee at #TLM23 MASH and MASLD session AASLD #LiverTwitter Petra Hirsova Mayo Clinic Gastroenterology & Hepatology

And last but not least, Dr Lucia Valenzuela Perez wrapping up the MASH session with more phenotypic insights on CD4 T cells in MASH ⁦AASLD⁩ #TLM23 #LiverTwitter

Learning about neutrophils in PSC from Abid Anwar AASLD #TLM23 #LiverTwitter Nidhi Sakrikar

Second annual Liver Cancer Shark Tank was once again standing room only. Congrats to all the presenters on the great pitches and to the winner Andrew Moon! Was fun to be a shark. #TLM2023 Amit G Singal Davide Povero, PhD, MBA @NDP1001 Daniela Sia

Today is #TransDayOfRemembrance. 320 trans people died in the US and 392 in Italy in 2023, with large majority being trans women and homicides. Today we remember those who we lost because our society was not able to protect them! #TransLivesMatter 🏳️‍⚧️

Friday 6pm and the Mayo Clinic Mayo Clinic Gastroenterology & Hepatology #livercancerresearch super group working tirelessly to make new discoveries!! #fightcancer

Seki lab at Cedars-Sinai is recruiting highly motivated postdoctoral scientists (<2 yrs after receiving the final degrees). We are studying liver fibrosis, alcohol-associated liver disease, and liver metastasis. Please contact me, if you are interested in doing research with us.

It’s Cholangiocarcinoma Awareness month. Our growing #CCA discovery science team celebrated #WorldCCADAY. 5 teams under one #CCA umbrella all with one mission: to improve outcomes for our CCA patients. #greenforCCA Cholangiocarcinoma Foundation

I am beyond grateful and honored to receive the 2024 Cholangiocarcinoma Foundation research award!! So excited to continue investigating the metabolic vulnerabilities driving ferroptosis in CCA. A special big thank to my mentors and my team at Mayo Clinic Gastroenterology & Hepatology

What a better way to celebrate #pridemonth with pride happy hour at D&D and #twincitiespride marching on the pride parade representing Mayo Clinic 🏳️‍🌈🏳️‍⚧️🌈🤩

So very thankful for this prestigious award AASLD Foundation 😍

Ferroptosis + Ox. stress+ Lipid Metabolism = the best combo!! So looking forward to attending this FASEB conference to learn from the best!! 🤩

Great job Peyton Classon presenting our poster on BAP1 and #ferroptosis in cholangiocarcinoma. Go IronTeam!!! #TLM2024 AASLD Cholangiocarcinoma Foundation Mayo Clinic Gastroenterology & Hepatology

Extremely grateful for the continued support from the Steward Mather Foundation and Cholangiocarcinoma Foundation. We are fully committed to advancing #cholangiocarcinoma research focusing on #ferroptosis and #cancermetabolism 👨🏻‍🔬